Impact of the NeuroCuple Device on Pain Management After Cesarean Delivery
Sponsor: Inova Health Care Services • ClinicalTrials.gov ID: NCT07185425
Recruiting for Similar Conditions?
Sponsors are looking for patients like you. See if you qualify for compensated research studies.
Check Eligibility →Description
This will be a single-center, sham-controlled, 3 arms, randomized (1:1:1) prospective study in females undergoing cesarean delivery to investigate the impact of NeuroCuple™ non-pharmacological analgesic device for management of postoperative pain. The investigators hypothesize that women treated with the Neurocuple device will experience less pain and consequently require less opioid pain medication after cesarean delivery compared to women who receive standard post-surgical medication.
Interventions
-
NeuroCuple
(Device)
Device around the abdomen over c-section bandages in the PACU
-
Sham
(Device)
Device around the abdomen over c-section bandages in the PACU
Eligibility criteria
Conditions
Locations
- Inova Fairfax Medical Campus — Falls Church, Virginia, United States
Partner with Nurenyx
Showcase your study to thousands of motivated patients matching your criteria.
Learn MoreOfficial Source
Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
View Official Record